Hello, welcome to Tosun!
会员中心

Product introduction:

Mesalazine is the active component of SASP in the treatment of ulcerative colitis. Mesalazine can inhibit the synthesis of prostaglandins and the formation of leukotrienes, which can significantly inhibit the inflammation of intestinal mucosa. Mesalazine can inhibit the synthesis of prostaglandins in a dose-dependent manner and reduce the release of PGE2 in human colonic mucosa.

市场价:

  • Product information
  • 产品描述
  • 参数配置

1、 Product introduction

Chinese Name

English Name

Declaration Type

Department

ReportableDosage Form

Declaration Progress

Strength

CAS

美沙拉嗪

Mupirocin

5+4

Gastroenterology

Tablets, enteric coated tablets, sustained-release granules, sustained-release

tablets, suppositories, enteric coated tablets, enemas

Already accepted

0.25mg、55mg、250mg、500mg、1g、60ml、4g

89-57-6

Indication】

    Anti ulcerative colitis.

Reportable Dosage Form &Strength】

      Tablets: 0.25g, 55mg; enteric coated tablets: 250mg, 500mg 'sustained-release granules: 500mg; sustained-release tablets: 500mg; suppository: 1g, 500mg; enteric coated tablets: 500mg; enema: 60ml: 4g

Development Progress】

     Already accepted

2、Domestic Declaration


Declaration TypeReportable Dosage FormNumber of Declared PreparationsNumber of Existing Preparation Enterprises
5+4Tablet, enteric-coated tablet, sustained-release granule, sustained-release tablet, suppository, enteric-coated film tablet, enemaEnteric coated granules: 1 imported
Enteric coated sustained release tablets: 1 imported
Enteric coated tablets: 3 domestic
Enema fluid: 1 domestic, suppository: 2 imported
Slow release granules: 2 imported and 1 domestic
Sustained release tablets: 3 imported
Controlled release capsule: 1 domestic
Enteric coated tablets: 1 imported, 3 domestic
Enema fluid: 1 imported
Sustained release tablets: 1 imported
Suppository: 2 imported and 1 domestic
Slow release granules: 1 imported and 1 domestic

 Brinzolamide 布林佐胺 CAS号:138890-62-7

Guangzhou Tosun Pharmaceutical Ltd

FL 4-5,No.3, 2nd Kehui street, Science Park, Guangzhou High-tech Industrial Development Zone, Guangzhou, China. 510663

Tel: +86-20-66392521; Fax: +86-20-66392525


Mesalazine is the active component of SASP in the treatment of ulcerative colitis. Mesalazine can inhibit the synthesis of prostaglandins and the formation of leukotrienes, which can significantly inhibit the inflammation of intestinal mucosa. Mesalazine can inhibit the synthesis of prostaglandins in a dose-dependent manner and reduce the release of PGE2 in human colonic mucosa.

热门关键词: 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
MapsXML Maps  Maps
Phone

(86)18922121079

(86)18026299762

TOP